ArticleFrontiers in pediatrics2025
Novel AVPR2 mutations in congenital nephrogenic diabetes insipidus: clinical characteristics and genetic analysis.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Congenital nephrogenic diabetes insipidus (NDI) is a rare hereditary disorder caused by mutations in two critical genes: arginine vasopressin receptor 2 (AVPR2) and aquaporin 2 genes (AQP2). Mutations in AVPR2 gene, which are predominantly X-linked, account for a significant proportion of cases, particularly in men. Nevertheless, research on this condition in the western Chinese population remains limited. Methods: Eleven participants from nine families with NDI were screened for AVPR2 mutations. Their clinical features were documented, and genotype-phenotype associations were investigated. Results: This study included 11 pediatric patients with congenital NDI, comprising 10 boys and 1 girl. They were diagnosed between 1 month and 7 years of age. The clinical presentations included growth retardation, polydipsia, and polyuria in all patients (11), hypernatremia in 10, renal pelvis dilation in 4, absence of posterior pituitary high signal on magnetic resonance imaging in 3, unexplained fever in 3, and recurrent vomiting in 1 and mental retardation each in 1 patient. Genetic analysis revealed eight AVPR2 mutations among the 11 patients with congenital NDI, 3 of which were novel: p.Ile46Serfs*145, p.Ile177del, and p.Ser327Ilefs*30. Conclusions: In the largest case series of congenital NDI caused by AVPR2 mutations in the western Chinese population, eight AVPR2 mutations were identified, including three that were novel. This study enhances the existing literature by elucidating the clinical manifestations of congenital NDI by analyzing 11 cases and by identifying three novel mutation sites, thereby augmenting the genetic understanding of this condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.